BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3263276)

  • 1. Evidence for the non-reactive nature of lymphoid elements in serous effusions from patients with cancer.
    Rathmell A; Master PS; Scott CS
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1531-3. PubMed ID: 3263276
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic differentiation between reactive and malignant lymphoid cells in serous effusions.
    Johnson EJ; Scott CS; Parapia LA; Stark AN
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):245-50. PubMed ID: 2965018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions.
    Robinson E; Sher S; Mekori T
    Cancer Res; 1974 Jul; 34(7):1548-51. PubMed ID: 4275697
    [No Abstract]   [Full Text] [Related]  

  • 4. T and B lymphocyte markers in effusions of patients with non-Hodgkin's lymphoma.
    Krajewski AS; Dewar AE; Ramage EF
    J Clin Pathol; 1982 Nov; 35(11):1216-9. PubMed ID: 6982906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Blanchard DK; Kavanagh JJ; Sinkovics JG; Cavanagh D; Hewitt SM; Djeu JY
    Cancer Res; 1988 Nov; 48(22):6321-7. PubMed ID: 2972357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro induction of cytotoxic activity against carcinomatous pleural or peritoneal lymphoid cells cultivated with cytokines, and an immunological phenotypic analysis of the effector cells].
    Ebihara T; Koyama S
    Gan No Rinsho; 1990 Apr; 36(5):604-10. PubMed ID: 2325266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
    To A; Coleman DV; Dearnaley DP; Ormerod MG; Steele K; Neville AM
    J Clin Pathol; 1981 Dec; 34(12):1326-32. PubMed ID: 7035498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum CA 125 levels in patients with benign ascitic or pleural effusions.
    Mezger J; Wilmanns W; Lamerz R
    Tumour Biol; 1988; 9(1):47-52. PubMed ID: 3163160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions of patients with cancer.
    Domagala W; Emeson EE; Koss LG
    J Natl Cancer Inst; 1978 Aug; 61(2):295-300. PubMed ID: 308101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma.
    Ebihara T; Koyama S
    Tohoku J Exp Med; 1990 Sep; 162(1):49-63. PubMed ID: 2077678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell responses in patients with malignant pleural effusions.
    Potrykus AM; Steinmann G; Stein E; Mertelsmann R
    Br J Cancer; 1981 Apr; 43(4):471-7. PubMed ID: 6972223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate].
    Zhang JR; Zhang XY; Chen XT
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
    Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
    Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody.
    Czerniak B; Papenhausen PR; Herz F; Koss LG
    Cancer; 1985 Jun; 55(12):2783-8. PubMed ID: 3888371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of lymphocytes in pleurisy and in effusions due to pleural infiltration by chronic lymphocytic leukemia cells.
    Boccato P; Saran B; Pasini L; Briani G
    Acta Cytol; 1978; 22(5):284-5. PubMed ID: 310227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.